• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型戈谢病同胞对疾病严重程度。

Disease severity in sibling pairs with type 1 Gaucher disease.

机构信息

Gaucher Clinic, Shaare Zedek Medical Center, Jerusalem, Israel.

出版信息

J Inherit Metab Dis. 2010 Feb;33(1):79-83. doi: 10.1007/s10545-009-9024-7. Epub 2010 Jan 5.

DOI:10.1007/s10545-009-9024-7
PMID:20049528
Abstract

The only prognostic markers in Gaucher disease, the most common lysosomal storage disorder, are young age at first symptom/sign and the presence of null/severe mutations, both being predictive of more severe phenotypes. Therefore, it would be helpful to know whether siblings with the same genotype can be expected to experience comparable phenotypic expression. All non-neuronopathic sibling pairs in our referral clinic (1993-2008) with the same genotype were included. For each pair, gender, date of birth, severity score index at presentation, age at diagnosis and first symptom/sign, presence of bone involvement, spleen status, and use of enzyme replacement therapy were tabulated. There were 90 pairs of siblings: two sets of identical twins; 24 pairs of brothers, 24 pairs of sisters, and 42 pairs of mixed gender. For all measures of disease severity used, only in sibling pairs with an older sister and a younger brother were phenotypes significantly different between siblings. Thus, this large cohort of sibling pairs with type 1 Gaucher disease confirmed that, in general, the phenotypic expression in the younger sibling will be similar enough to that of an older affected sibling that genetic counseling may use those findings in a prognostic way.

摘要

戈谢氏病是最常见的溶酶体贮积症,目前唯一的预后标志物是首发症状/体征的年龄较小和存在无效/严重突变,两者均提示更严重的表型。因此,了解具有相同基因型的同胞是否可能出现可比的表型表达是有帮助的。纳入了我院(1993-2008 年)就诊的所有具有相同基因型的非神经病变同胞对。对于每一对,记录了性别、出生日期、就诊时的严重程度评分指数、诊断年龄和首发症状/体征、是否存在骨骼受累、脾脏状态以及是否使用酶替代疗法。共有 90 对同胞:两对同卵双胞胎;24 对兄弟,24 对姐妹,42 对混合性别。对于使用的所有疾病严重程度指标,只有姐姐和弟弟年龄相差较大的同胞对之间,表型存在显著差异。因此,本研究中这一大群 1 型戈谢氏病的同胞对证实,一般来说,年幼同胞的表型表达与受影响的年长同胞足够相似,遗传咨询可以根据这些发现进行预后评估。

相似文献

1
Disease severity in sibling pairs with type 1 Gaucher disease.1 型戈谢病同胞对疾病严重程度。
J Inherit Metab Dis. 2010 Feb;33(1):79-83. doi: 10.1007/s10545-009-9024-7. Epub 2010 Jan 5.
2
Gaucher disease: variability in phenotype among siblings.戈谢病:同胞间表型的变异性。
J Inherit Metab Dis. 2004;27(5):659-69. doi: 10.1023/b:boli.0000042983.60840.f3.
3
A monozygotic twin pair with highly discordant Gaucher phenotypes.一对高度不一致的戈谢病表型的同卵双胞胎。
Blood Cells Mol Dis. 2011 Jan 15;46(1):39-41. doi: 10.1016/j.bcmd.2010.10.007. Epub 2010 Nov 5.
4
Intrauterine growth and intelligence within sibling pairs: findings from the Aberdeen children of the 1950s cohort.同胞对中宫内生长与智力:20世纪50年代阿伯丁队列儿童的研究结果
Pediatrics. 2006 May;117(5):e894-902. doi: 10.1542/peds.2005-2412.
5
Adult siblings of individuals with Down syndrome versus with autism: findings from a large-scale US survey.唐氏综合征患者与自闭症患者的成年兄弟姐妹对比:来自美国一项大规模调查的结果。
J Intellect Disabil Res. 2007 Dec;51(Pt 12):1018-29. doi: 10.1111/j.1365-2788.2007.00994.x.
6
Phenotypic heterogeneity in patients with Gaucher disease and the N370S/V394L genotype.戈谢病患者及N370S/V394L基因型的表型异质性。
Genet Test. 2005 Spring;9(1):26-9. doi: 10.1089/gte.2005.9.26.
7
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.小儿非神经元型戈谢病:临床表现、诊断与评估。共识声明。
Eur J Pediatr. 2004 Feb;163(2):58-66. doi: 10.1007/s00431-003-1362-0. Epub 2003 Dec 16.
8
Sibling relationship quality and adolescent delinquency: a latent growth curve approach.兄弟姐妹关系质量与青少年犯罪:潜在增长曲线方法。
J Fam Psychol. 2010 Aug;24(4):400-10. doi: 10.1037/a0020351.
9
Siblings of individuals with autism or Down syndrome: effects on adult lives.患有自闭症或唐氏综合征个体的兄弟姐妹:对成年生活的影响。
J Intellect Disabil Res. 2007 Sep;51(Pt 9):682-96. doi: 10.1111/j.1365-2788.2007.00954.x.
10
Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS).II型黏多糖贮积症临床表现的家族内变异性:来自亨特结果调查(HOS)的数据。
Am J Med Genet A. 2018 Feb;176(2):301-310. doi: 10.1002/ajmg.a.38551. Epub 2017 Dec 6.

引用本文的文献

1
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease.PGRN 与 Gba1 D409V 突变剂量之间的内在联系增强了戈谢病。
Hum Mol Genet. 2024 Oct 7;33(20):1771-1788. doi: 10.1093/hmg/ddae113.
2
Non-immune Hemolysis in Gaucher Disease and Review of the Literature.戈谢病中的非免疫性溶血及文献综述
Rambam Maimonides Med J. 2021 Jul 20;12(3):e0025. doi: 10.5041/RMMJ.10446.
3
Aortic calcification in Gaucher disease: a case report.戈谢病中的主动脉钙化:一例报告

本文引用的文献

1
The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).女性戈谢病患者:酶替代疗法对关键生殖事件(月经、妊娠和绝经)的影响
Blood Cells Mol Dis. 2009 Nov-Dec;43(3):264-88. doi: 10.1016/j.bcmd.2009.04.003. Epub 2009 Jun 6.
2
Gaucher disease: variability in phenotype among siblings.戈谢病:同胞间表型的变异性。
J Inherit Metab Dis. 2004;27(5):659-69. doi: 10.1023/b:boli.0000042983.60840.f3.
3
Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.
Appl Clin Genet. 2018 Oct 17;11:107-110. doi: 10.2147/TACG.S180995. eCollection 2018.
4
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease.几丁质酶蛋白 3 样蛋白 1:一种颗粒蛋白下游分子,戈谢病的潜在生物标志物。
EBioMedicine. 2018 Feb;28:251-260. doi: 10.1016/j.ebiom.2018.01.022. Epub 2018 Jan 31.
5
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.戈谢病的病理生理学、临床表现及治疗综述
Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441.
6
Association Between Progranulin and Gaucher Disease.颗粒蛋白前体与戈谢病之间的关联
EBioMedicine. 2016 Sep;11:127-137. doi: 10.1016/j.ebiom.2016.08.004. Epub 2016 Aug 4.
7
Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.诱发电位和神经认知功能在儿科埃及戈谢病患者酶替代治疗:单中心经验。
J Inherit Metab Dis. 2013 Nov;36(6):1025-37. doi: 10.1007/s10545-013-9597-z. Epub 2013 Mar 19.
8
A disease severity scoring system for children with type 1 Gaucher disease.1 型戈谢病儿童疾病严重程度评分系统。
Eur J Pediatr. 2013 Jan;172(1):39-43. doi: 10.1007/s00431-012-1830-5. Epub 2012 Sep 20.
9
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.全基因组关联研究发现 N370S 纯合子 Gaucher 病与 CLN8 基因的候选性,该基因可能是导致表型极端变异的遗传修饰因子。
Am J Hematol. 2012 Apr;87(4):377-83. doi: 10.1002/ajh.23118. Epub 2012 Mar 3.
10
Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl.戈谢病中葡糖脑苷脂酶活性降低与由于与 TCP1 和 c-Cbl 的异常相互作用导致的定量酶丢失平行。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21665-70. doi: 10.1073/pnas.1014376107. Epub 2010 Nov 22.
通过电喷雾电离串联质谱法测定羊水中的寡糖和糖脂:溶酶体贮积病的宫内指标
Mol Genet Metab. 2004 Nov;83(3):231-8. doi: 10.1016/j.ymgme.2004.07.015.
4
Twin pairs showing discordance of phenotype in adult Gaucher's disease.在成年戈谢病中表现出表型不一致的双胞胎对。
QJM. 2004 Apr;97(4):199-204. doi: 10.1093/qjmed/hch036.
5
Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity.戈谢病的基因型、表型和生化标志物之间的相关性:对疾病严重程度预测的意义。
Mol Genet Metab. 2002 Jan;75(1):46-55. doi: 10.1006/mgme.2001.3269.
6
Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy.1型戈谢病患儿:接受和未接受酶替代疗法步入成年期的情况
Isr Med Assoc J. 2000 Feb;2(2):80-1.
7
Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease.低剂量低频伊米苷酶作为Ⅰ型戈谢病患者酶替代治疗的起始方案
QJM. 1998 Jul;91(7):483-8. doi: 10.1093/qjmed/91.7.483.
8
Gaucher's disease: genetic counselling and population screening.戈谢病:遗传咨询与群体筛查
Baillieres Clin Haematol. 1997 Dec;10(4):779-92. doi: 10.1016/s0950-3536(97)80040-6.
9
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.戈谢病的低剂量酶替代疗法:年龄、性别、基因型和临床特征对治疗反应的影响。
Am J Med. 1994 Jul;97(1):3-13. doi: 10.1016/0002-9343(94)90042-6.
10
Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
Lancet. 1989 Aug 12;2(8659):349-52. doi: 10.1016/s0140-6736(89)90536-9.